OTCPK:SMLR

Stock Analysis Report

Executive Summary

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.

Share Price & News

How has Semler Scientific's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

9.1%

OTCPK:SMLR

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

34.8%

OTCPK:SMLR

9.9%

US Medical Equipment

1.6%

US Market

SMLR outperformed the Medical Equipment industry which returned 9.7% over the past year.

SMLR outperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

SMLRIndustryMarket
7 Day9.1%0.5%-0.02%
30 Day-2.2%0.09%2.7%
90 Day3.7%2.0%1.4%
1 Year34.8%34.8%10.8%9.9%3.8%1.6%
3 Year2400.0%2400.0%69.0%63.9%45.2%35.8%
5 Year1255.4%1255.4%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is Semler Scientific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Semler Scientific undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Semler Scientific's share price is below the future cash flow value, and at a moderate discount (> 20%).

Semler Scientific's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Semler Scientific is good value based on earnings compared to the US Medical Equipment industry average.

Semler Scientific is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Semler Scientific is poor value based on expected growth next year.


Price Based on Value of Assets

Semler Scientific is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Semler Scientific expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

20.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Semler Scientific's revenue is expected to grow significantly at over 20% yearly.

Semler Scientific's earnings are expected to grow significantly at over 20% yearly.

Semler Scientific's revenue growth is expected to exceed the United States of America market average.

Semler Scientific's earnings growth is expected to exceed the United States of America market average.

Semler Scientific's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Semler Scientific will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Semler Scientific performed over the past 5 years?

54.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Semler Scientific has delivered over 20% year on year earnings growth in the past 5 years.

Semler Scientific's 1-year earnings growth exceeds its 5-year average (209% vs 54.3%)

Semler Scientific's earnings growth has exceeded the US Medical Equipment industry average in the past year (209% vs 28.2%).


Return on Equity

Semler Scientific made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%).


Return on Assets

Semler Scientific used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Unable to establish if Semler Scientific improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.


Next Steps

Financial Health

How is Semler Scientific's financial position?


Financial Position Analysis

Semler Scientific is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Semler Scientific's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Semler Scientific has no debt.

Semler Scientific has no debt compared to 5 years ago when it was 3.7%.

Semler Scientific has no debt, it does not need to be covered by operating cash flow.

Semler Scientific has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Low level of unsold assets.

Semler Scientific has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is Semler Scientific's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Semler Scientific's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Semler Scientific's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Semler Scientific has not reported any payouts.

Unable to verify if Semler Scientific's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Semler Scientific has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Semler Scientific's salary, the management and board of directors tenure and is there insider trading?

6.7yrs

Average management tenure


CEO

Doug Murphy-Chutorian (65yo)

7yrs

Tenure

US$1,578,367

Compensation

Dr. Douglas Murphy-Chutorian, also known as Doug, M.D. has been the Chief Executive Officer of Semler Scientific, Inc since October 31, 2012 and served as its President. Dr. Murphy-Chutorian serves as the  ...


CEO Compensation Analysis

Doug's remuneration is higher than average for companies of similar size in United States of America.

Doug's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

6.7yrs

Average Tenure

65yo

Average Age

The average tenure for the Semler Scientific management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

5.3yrs

Average Tenure

68.5yo

Average Age

The tenure for the Semler Scientific board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$3,928,54007 May 19
William H. Chang
EntityIndividual
Shares89,285
Max PriceUS$44.00

Ownership Breakdown


Management Team

  • Doug Murphy-Chutorian (65yo)

    CEO & Director

    • Tenure: 7yrs
    • Compensation: US$1.58m
  • Bob McRae (50yo)

    Chief Technical Officer

    • Tenure: 0yrs
    • Compensation: US$256.96k
  • Dennis Rosenberg (65yo)

    Chief Marketing Officer

    • Tenure: 6.7yrs
  • Andy Weinstein (55yo)

    Senior Vice President of Finance & Accounting

    • Tenure: 0.9yrs
    • Compensation: US$276.98k
  • Herbert Semler (91yo)

    Founder & Chairman Emeritus

    • Tenure: 0yrs
    • Compensation: US$47.84k

Board Members

  • Doug Murphy-Chutorian (65yo)

    CEO & Director

    • Tenure: 7yrs
    • Compensation: US$1.58m
  • Abbie Leibowitz (72yo)

    Independent Director

    • Tenure: 5.3yrs
    • Compensation: US$71.95k
  • Herbert Semler (91yo)

    Founder & Chairman Emeritus

    • Tenure: 0yrs
    • Compensation: US$47.84k
  • Wayne Pan (55yo)

    Independent Director

    • Tenure: 5.3yrs
    • Compensation: US$84.62k

Company Information

Semler Scientific, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Semler Scientific, Inc.
  • Ticker: SMLR
  • Exchange: OTCPK
  • Founded: 2007
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$293.531m
  • Shares outstanding: 6.52m
  • Website: https://www.semlerscientific.com

Number of Employees


Location

  • Semler Scientific, Inc.
  • 911 Bern Court
  • Suite 110
  • San Jose
  • California
  • 95112
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SMLROTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2014

Biography

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products inc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/19 00:16
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.